SS-31 HA

$70.00
Availability:
In Stock
Adding to cart… The item has been added

Product Overview

Compound: SS‑31 (Elamipretide, Bendavia, MTP‑131), a mitochondria-targeted tetrapeptide (D‑Arg‑Dmt‑Lys‑Phe‑NH₂)

Form: Lyophilized powder, research-grade purity ≥95‑99%.

For laboratory research only—NOT for human or veterinary use.

Batch-tested ≥95‑99% purity by HPLC. COA available upon request — email providers@theratideusa.com.

  • Antioxidant & mitochondrial protector: Scavenges ROS, stabilizes mitochondrial membranes, prevents permeability pore formation, and supports ATP production :contentReference[oaicite:1]{index=1}.
  • Cardio & renal disease: Shows benefits in kidney and heart disease models by reducing oxidative damage and fibrosis :contentReference[oaicite:2]{index=2}.
  • Neurological health: Protects hippocampal cells from oxidative stress, preserves cognition and cerebrovascular function in aged mice :contentReference[oaicite:3]{index=3}.
  • Skeletal muscle & aging: Rapidly reverses age-related mitochondrial deficits and improves muscle energetics and endurance :contentReference[oaicite:4]{index=4}.
  • Clinical trials: Under evaluation for Barth syndrome, mitochondrial myopathies, and heart failure; mixed outcomes :contentReference[oaicite:5]{index=5}.

Evidence includes preclinical and clinical data, no regulatory approvals yet.

What is SS‑31 used for?
Investigated as a mitochondrial protector in kidney, heart, brain, and muscle disease models.

How does it work?
Targets mitochondrial cardiolipin to improve electron transport, reduce ROS, stabilize membrane structure and function :contentReference[oaicite:6]{index=6}.

Any clinical use?
Tested in Phase II/III trials (e.g., Barth syndrome, heart failure), with mixed results :contentReference[oaicite:7]{index=7}.

Typical dosing?
Preclinical: 3–40 mg/kg (IP/SubQ). Clinical dosages vary by trial protocol :contentReference[oaicite:8]{index=8}.

Known side effects?
Generally well tolerated; injection site redness possible in SubQ studies :contentReference[oaicite:9]{index=9}.

For research use only—not for human or veterinary use, nor intended as a dietary supplement.

Safety: Handle with appropriate lab protocols, PPE, and store at ≤\u201320 °C.

FDA Notice: Statements not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease.

All products offered by TheraTide USA are strictly intended for research and development purposes only.

None of the statements on this website have been evaluated by the U.S. Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.

TheraTide USA is a research chemical supplier. We are not a compounding pharmacy or a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.